TNFSF10 and neoplasm: Immunohistochemistry of tumor sections demonstrated that all groups treated with OAds had reduced viability, as determined by Ki67 staining, and the strongest inhibition was mediated by the two improved OAds Ad5/3-Δ19K-.Luc and Ad5/3-TRAIL transferred by MSCs (Figure 6B).